Leaflet DIFTAVAX suspension for injection in a pre-filled syringe


Indicated for: prevention of diphtheria, tetanus and pertussis

Route of administration: injectable

Substance: adult-type adsorbed diphtheria + tetanus vaccine (vaccine)

ATC: J07AM51 (Antiinfectives for systemic use | Bacterial vaccines | Tetanus vaccines)

The adsorbed diphtheria and tetanus vaccine for adults (dT) is used to prevent diphtheria and tetanus, two serious infectious diseases caused by bacteria. This vaccine contains reduced doses of diphtheria and tetanus toxoids, specifically formulated for adults and adolescents to reduce the risk of adverse reactions.

The vaccine is administered intramuscularly, usually as a booster dose every 10 years, according to vaccination recommendations. It is particularly important for individuals traveling to endemic areas, healthcare workers, and those exposed to contaminated wounds.

Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.

The dT vaccine is an essential preventive measure for maintaining immunity against diphtheria and tetanus, helping to protect public health and prevent the severe complications associated with these diseases.

General data about DIFTAVAX

  • Substance: adult-type adsorbed diphtheria + tetanus vaccine
  • Date of last drug list: 01-01-2016
  • Commercial code: W62142002
  • Pharmaceutical form: suspension for injection in a pre-filled syringe
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for adult-type adsorbed diphtheria + tetanus vaccine